Global Pharmaceuticals & Biotech Big Green Snowflakes

Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi

Market Cap: ₺48.5b

A pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide.

Bioqual

Market Cap: US$39.0m

Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.

GC Biopharma

Market Cap: ₩1.5t

A biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.

Astena Holdings

Market Cap: JP¥20.9b

Manufactures and sells medicine-related products in Japan.

Yantai Dongcheng Pharmaceutical GroupLtd

Market Cap: CN¥13.1b

Engages in the manufacture and sale of biochemical APIs, finished dosage forms, nuclide drugs, and healthy products for cardiovascular, antitumor, urology, orthopedics, and other therapeutic areas.

Jilin Jian Yisheng Pharmaceutical

Market Cap: CN¥2.7b

Engages in the research, development, production, wholesale, retail, import, and export of pharmaceutical products in China.

Patrys

Market Cap: AU$9.2m

Develops and commercializes antibody technologies for the treatment of cancer in Australia.

InventisBio

Market Cap: CN¥20.3b

A clinical stage biotech company, engages in the discovery and development of therapeutics for cancer and metabolic diseases in China and the United States.

Sino BiologicalInc

Market Cap: CN¥9.6b

Provides recombinant protein and antibody reagents for life science researchers worldwide.

CanSino Biologics

Market Cap: HK$17.6b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

China Health Group

Market Cap: HK$169.2m

An investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China.

Percheron Therapeutics

Market Cap: AU$9.8m

Engages in the research and development of novel antisense pharmaceuticals for cancer and rare diseases in Australia.

Changchun BCHT Biotechnology

Market Cap: CN¥9.5b

Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally.

Alphamab Oncology

Market Cap: HK$10.5b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biotherapeutics for cancer treatment in the People’s Republic of China.

Shenzhen Neptunus Interlong Bio-technique

Market Cap: HK$251.7m

Engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China.

Beijing Science Sun Pharmaceutical

Market Cap: CN¥5.9b

A biopharmaceutical company, engages in the research and development, production, and sales of injections in China.

Heartseed

Market Cap: JP¥85.5b

Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.

Uni-Bio Science Group

Market Cap: HK$931.5m

An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.

Laekna

Market Cap: HK$6.0b

An investing holding company, engages in the discovering, development, and commercialization of therapies for patients with cancer, metabolic diseases, and liver fibrosis in the People’s Republic of China, the United States of America, and South Korea.

Nanjing Leads Biolabs

Market Cap: HK$12.5b

A clinical-stage biotechnology company, engages in the research, development, and commercialisation of novel antibody drugs worldwide.

Accretion Pharmaceuticals

Market Cap: ₹700.3m

Manufactures and sells pharmaceutical products in India.

Indoco Remedies

Market Cap: ₹25.5b

Manufactures and markets formulations and active pharmaceutical ingredients in India and internationally.

Emmessar Biotech & Nutrition

Market Cap: ₹136.0m

A healthcare company, provides nutritional products in India and internationally.

Zenith Drugs

Market Cap: ₹1.2b

Manufactures and trades in medicines.

Ambalal Sarabhai Enterprises

Market Cap: ₹2.4b

Manufactures, markets, and supplies pharmaceutical products in India and internationally.

Syschem (India)

Market Cap: ₹2.3b

Engages in the production and sale of active pharmaceuticals ingredients (API), intermediates, bulk drugs, and specialty chemicals in India.

Myriad Genetics

Market Cap: US$648.5m

A molecular diagnostic testing and precision medicine company, develops and provides molecular tests in the United States and internationally.

Zai Lab

Market Cap: US$3.5b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

Alpha Cognition

Market Cap: US$158.1m

A biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada.

10x Genomics

Market Cap: US$1.7b

A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.

Camp4 Therapeutics

Market Cap: US$40.1m

A clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases.

Formycon

Market Cap: €402.7m

A biotechnology company, develops biosimilar drugs in Germany and Switzerland.

Cumberland Pharmaceuticals

Market Cap: US$50.9m

A specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally.

Dyadic International

Market Cap: US$35.5m

A biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally.

Pliant Therapeutics

Market Cap: US$107.4m

A biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases.

Immix Biopharma

Market Cap: US$74.5m

A clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia.